US Patent Issued to Celros Biotech on Aug. 25 for "Thiohydantoin derivatives and uses thereof" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,694, issued on Aug. 25, was assigned to Celros Biotech (Seoul, South Korea).

"Thiohydantoin derivatives and uses thereof" was invented by Yun Soo Bae (Gyeonggi-do, South Korea) and Da Un Jeong (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a thiohydantoin derivative and a composition for preventing or treating NADPH oxidase (NOX)-associated diseases comprising same, and can be used to treat NADPH oxidase (NOX)-associated diseases through excellent actions on NOX inhibition."

The patent was filed on Aug. 27, 2021, under Application No. 18/043,408.

*For further information, including images, chart...